封面
市场调查报告书
商品编码
1632582

胰臟癌治疗市场规模、份额、趋势分析:按类型、治疗方法、分销管道、地区、细分市场预测,2025-2030

Pancreatic Cancer Treatment Market Size, Share & Trends Analysis By Type, By Treatment, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 153 Pages | 商品交期: 2-10个工作天内

价格

胰臟癌治疗市场的成长与趋势:

Grand View Research 的最新报告显示,到 2030 年,全球胰臟癌治疗市场规模预计将达到 58.4 亿美元。

预计2025年至2030年该市场将以12.30%的复合年增长率成长。烟草消费、吸烟、肥胖的增加以及对各种可用治疗方案的认识不断提高正在推动全球市场的成长。胰臟癌的发病高峰年龄在65岁至75岁之间。因此,老年人口的增加预计也将推动预测期内的成长。

根据美国最危险的恶性肿瘤之一,也是癌症死亡的第四大原因。这些因素被认为将推动预测期内的市场成长。

胰臟癌治疗市场报告亮点

  • 根据这项研究,外分泌胰臟癌是最常见的胰臟癌类型,占所有胰臟癌的95%以上。
  • 在治疗类型中,标靶治疗被认为是最有效的治疗选择,并且占据最大份额,因为它可以阻止癌细胞的生长和扩散而不伤害健康细胞。
  • 由于先进治疗方案的高采用率和高度发展的医疗基础设施,北美在 2024 年占据了最大的销售份额。
  • 预计亚太地区将在预测期内实现强劲增长,这主要是由于政府倡议的增加、对胰腺癌治疗方案的认识不断提高以及用于有效治疗的高度先进的医疗基础设施的可用性。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章胰臟癌治疗市场变数、趋势和范围

  • 母市场展望
  • 配套市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 胰臟癌治疗分析工具
    • 波特的分析
    • PESTEL分析

第四章胰臟癌治疗市场:按类型估计和趋势分析

  • 胰臟癌治疗市场:类型细分仪表板
  • 胰臟癌治疗市场:按类型分類的波动分析,百万美元,2024 年和 2030 年
  • 外分泌
  • 内分泌

第五章胰臟癌治疗市场:治疗评估与趋势分析

  • 胰臟癌治疗市场:治疗细分仪表板
  • 胰臟癌治疗市场:治疗变异分析,百万美元,2024 年和 2030 年
  • 化疗
  • 放射治疗
  • 其他的

第六章胰臟癌治疗市场:通路估算及趋势分析

  • 胰臟癌治疗市场:通路细分仪表板
  • 胰臟癌治疗市场:通路波动分析,百万美元,2024 年和 2030 年
  • 医院药房
  • 零售药房
  • 其他的

第七章胰臟癌治疗市场:区域估算与趋势分析

  • 2024 年和 2030 年按地区分類的胰臟癌治疗市场占有率,百万美元
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 挪威
    • 瑞典
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 南非

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Accuray Incorporated
    • AstraZeneca
    • Novartis AG
    • Pfizer Inc.
    • Genentech, Inc.(F. Hoffmann-La Roche Ltd)
    • Bristol-Myers Squibb Company
    • Ipsen Pharma
    • Eli Lilly and Company
    • Siemens Healthineers AG(Varian Medical Systems, Inc., part of the company)
    • Elekta AB
Product Code: GVR-1-68038-774-2

Pancreatic Cancer Treatment Market Growth & Trends:

The global pancreatic cancer treatment market size is anticipated to reach USD 5.84 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 12.30% from 2025 to 2030. Increasing tobacco consumption, smoking, obesity, and growing awareness pertaining to various treatment options available are propelling the market growth at a global level. The peak incidence of pancreatic cancer is seen in the age group of 65 to 75 years. Thus, growing geriatric population is also expected to drive the growth during the forecast period.

According to an article published in the National Center for Biotechnology Information in 2015, pancreatic cancer is one of the most dangerous malignancies and is the fourth most common cause of cancer deaths in the U.S. Furthermore, pancreatic cancer is expected to be the second common cause of death in the U.S., by 2030. These factors together would propel the market growth in the forecast period.

Pancreatic Cancer Treatment Market Report Highlights:

  • The study suggests that exocrine cancer is by far the most common type of pancreatic cancer accounting for more than 95% of the overall pancreatic cancer types.
  • Among the treatment types, targeted therapy occupied the largest share since it is considered as the most effective treatment option, which blocks the growth and spread of cancer cells without damaging healthy cells.
  • North America dominated the segment with the largest revenue share in 2024 due to high adoption rate of advanced treatment options and highly developed healthcare infrastructure.
  • Asia Pacific is anticipated to show a significant growth during the forecast period, mainly due to increasing government initiatives, growing awareness regarding the treatment options for pancreatic cancer, and the availability of highly sophisticated medical infrastructure for effective treatment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pancreatic Cancer Treatment Market Variables, Trends, & Scope

  • 3.1. Parent Market Outlook
  • 3.2. Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Rising Prevalence of Pancreatic Cancer Globally
      • 3.3.1.2. Advancements in Modern Therapeutics
      • 3.3.1.3. Growing Investments in Pancreatic Cancer R&D
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. High Cost of Advanced Therapies
      • 3.3.2.2. Stringent Regulatory and Reimbursement Challenges
  • 3.4. Pancreatic Cancer Treatment Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Pancreatic Cancer Treatment Market: By Type Estimates & Trend Analysis

  • 4.1. Pancreatic Cancer Treatment Market: Type Segment Dashboard
  • 4.2. Pancreatic Cancer Treatment Market: By Type Movement Analysis, USD Million, 2024 & 2030
  • 4.3. Exocrine
    • 4.3.1. Exocrine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Endocrine
    • 4.4.1. Endocrine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pancreatic Cancer Treatment Market: Treatment Estimates & Trend Analysis

  • 5.1. Pancreatic Cancer Treatment Market: Treatment Segment Dashboard
  • 5.2. Pancreatic Cancer Treatment Market: By Treatment Movement Analysis, USD Million, 2024 & 2030
  • 5.3. Chemotherapy
    • 5.3.1. Chemotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Radiation Therapy
    • 5.4.1. Radiation Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pancreatic Cancer Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Pancreatic Cancer Treatment Market: Distribution Channel Segment Dashboard
  • 6.2. Pancreatic Cancer Treatment Market: Distribution Channel Movement Analysis, USD Million, 2024 & 2030
  • 6.3. Hospital Pharmacies
    • 6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Retail Pharmacies
    • 6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pancreatic Cancer Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Pancreatic Cancer Treatment Market Share, By Region, 2024 & 2030, USD Million
  • 7.2. North America
    • 7.2.1. North America Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018- 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Norway
      • 7.3.8.1. Norway Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Sweden Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Kuwait
      • 7.6.4.1. Kuwait Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. South Africa Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Accuray Incorporated
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. AstraZeneca
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Novartis AG
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Pfizer Inc.
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Genentech, Inc. (F. Hoffmann-La Roche Ltd)
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Bristol-Myers Squibb Company
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Ipsen Pharma
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Eli Lilly and Company
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Siemens Healthineers AG (Varian Medical Systems, Inc., part of the company)
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Elekta AB
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 5 Global pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 6 North America pancreatic cancer treatment market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 8 North America pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 9 North America pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10 U.S. pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 12 U.S. pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 Canada pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 14 Canada pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 15 Canada pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Mexico pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 17 Mexico pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 18 Mexico pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Europe pancreatic cancer treatment market, by Country, 2018 - 2030 (USD Million)
  • Table 20 Europe pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 21 Europe pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 22 Europe pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 Germany pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 24 Germany pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 25 Germany pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 UK pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 27 UK pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 28 UK pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 France pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 30 France pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 31 France pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 Italy pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 33 Italy pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 34 Italy pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 Spain pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 36 Spain pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 37 Spain pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 Denmark pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 39 Denmark pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 40 Denmark pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Sweden pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 42 Sweden pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 43 Sweden pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Norway pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 45 Norway pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 46 Norway pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific pancreatic cancer treatment market, by Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 China pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 52 China pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 53 China pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 Japan pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 55 Japan pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 56 Japan pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 57 India pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 58 India pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 59 India pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60 South Korea pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 61 South Korea pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 62 South Korea pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63 Australia pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 64 Australia pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 65 Australia pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 Thailand pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 67 Thailand pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 68 Thailand pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69 Latin America pancreatic cancer treatment market, by Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 71 Latin America pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 72 Latin America pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 Brazil pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 74 Brazil pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 75 Brazil pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76 Argentina pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 77 Argentina pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 78 Argentina pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa pancreatic cancer treatment market, by Country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 South Africa pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 84 South Africa pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 85 South Africa pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 89 UAE pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 90 UAE pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 91 UAE pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92 Kuwait pancreatic cancer treatment market, by Type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait pancreatic cancer treatment market, by Treatment, 2018 - 2030 (USD Million)
  • Table 94 Kuwait pancreatic cancer treatment market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Pancreatic Cancer Treatment Market Segmentation
  • Fig. 8 Market Snapshot, 2024
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Pancreatic cancer treatment market: Type movement analysis
  • Fig. 16 Pancreatic cancer treatment market: Type outlook and key takeaways
  • Fig. 17 Exocrine pancreatic cancer treatment market estimates and forecasts, 2018 - 2030
  • Fig. 18 Endocrine pancreatic cancer treatment market estimates and forecasts, 2018 - 2030
  • Fig. 19 Pancreatic cancer treatment market: Treatment movement analysis
  • Fig. 20 Pancreatic cancer treatment market: Treatment outlook and key takeaways
  • Fig. 21 Chemotherapy market estimates and forecasts, 2018 - 2030
  • Fig. 22 Radiation Therapy market estimates and forecasts, 2018 - 2030
  • Fig. 23 Others market estimates and forecasts, 2018 - 2030
  • Fig. 24 Pancreatic cancer treatment market: Distribution Channel movement analysis
  • Fig. 25 Pancreatic cancer treatment market: Distribution Channel outlook and key takeaways
  • Fig. 26 Hospital Pharmacies market estimates and forecasts, 2018 - 2030
  • Fig. 27 Retail Pharmacies market estimates and forecasts, 2018 - 2030
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030
  • Fig. 29 Regional Marketplace: Key Takeaways
  • Fig. 30 Regional Outlook, 2024 & 2030
  • Fig. 31 Global Pancreatic Cancer Treatment Market, Region Movement Analysis
  • Fig. 32 North America pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 34 Canada pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 35 Mexico pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 37 Germany pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 38 UK pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 39 France pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 Norway pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 46 Japan pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 47 China pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 48 India pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 49 Australia pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 50 South Korea pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 54 Argentina pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 55 Middle East and Africa pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 56 South Africa pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 57 Saudi Arabia pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 58 UAE pancreatic cancer treatment market, 2018 - 2030 (USD Million)
  • Fig. 59 Kuwait pancreatic cancer treatment market, 2018 - 2030 (USD Million)